|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
47,500,000 |
Market
Cap: |
2.01(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$38.65 - $65 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Amphastar Pharmaceuticals is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing and selling generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient (API) products. Co.'s reportable segments are: finished pharmaceutical products, which manufactures, markets and distributes Primatene Mist®, glucagon, enoxaparin, naloxone, phytonadione, lidocaine, epinephrine, various critical and non-critical care drugs; and API, which manufactures and distributes recombinant human insulin API and porcine insulin API for external customers and internal product development.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
1,000 |
384,322 |
579,546 |
794,601 |
Total Sell Value |
$42,551 |
$21,525,712 |
$32,066,990 |
$40,646,784 |
Total People Sold |
1 |
4 |
8 |
10 |
Total Sell Transactions |
2 |
10 |
25 |
62 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Shohet Stephen B. |
Director |
|
2017-11-30 |
4 |
OE |
$10.77 |
$84,674 |
D/D |
7,862 |
31,978 |
|
- |
|
Gerst Diane G. |
EVP, QA & Regulatory Affairs |
|
2017-11-28 |
4 |
AS |
$18.15 |
$9,493 |
D/D |
(523) |
31,210 |
|
- |
|
Shohet Stephen B. |
Director |
|
2017-11-22 |
4 |
AS |
$18.94 |
$148,895 |
D/D |
(7,862) |
24,116 |
|
- |
|
Shohet Stephen B. |
Director |
|
2017-11-22 |
4 |
OE |
$10.77 |
$84,674 |
D/D |
7,862 |
31,978 |
|
- |
|
Gerst Diane G. |
EVP, QA & Regulatory Affairs |
|
2017-11-21 |
4 |
AS |
$18.81 |
$9,839 |
D/D |
(523) |
31,733 |
|
- |
|
Shohet Stephen B. |
Director |
|
2017-11-16 |
4 |
AS |
$18.04 |
$141,862 |
D/D |
(7,862) |
24,116 |
|
- |
|
Shohet Stephen B. |
Director |
|
2017-11-16 |
4 |
OE |
$10.77 |
$84,674 |
D/D |
7,862 |
31,978 |
|
- |
|
Gerst Diane G. |
EVP, QA & Regulatory Affairs |
|
2017-11-15 |
4 |
AS |
$17.77 |
$9,292 |
D/D |
(523) |
32,256 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2017-11-13 |
4 |
OE |
$12.02 |
$2,242,831 |
I/I |
186,545 |
1,263,378 |
|
- |
|
Luo Mary Z. |
COO,Chief Scientist & Chairman |
|
2017-11-13 |
4 |
OE |
$12.02 |
$3,844,859 |
D/D |
319,792 |
1,897,847 |
|
- |
|
Shohet Stephen B. |
Director |
|
2017-11-09 |
4 |
AS |
$17.51 |
$145,845 |
D/D |
(7,862) |
24,116 |
|
- |
|
Shohet Stephen B. |
Director |
|
2017-11-09 |
4 |
OE |
$10.77 |
$84,674 |
D/D |
7,862 |
31,978 |
|
- |
|
Gerst Diane G. |
EVP, QA & Regulatory Affairs |
|
2017-11-07 |
4 |
AS |
$17.93 |
$9,375 |
D/D |
(523) |
32,779 |
|
- |
|
Shohet Stephen B. |
Director |
|
2017-11-02 |
4 |
AS |
$18.37 |
$144,460 |
D/D |
(7,862) |
24,116 |
|
- |
|
Shohet Stephen B. |
Director |
|
2017-11-02 |
4 |
OE |
$10.77 |
$84,674 |
D/D |
7,862 |
31,978 |
|
- |
|
Shohet Stephen B. |
Director |
|
2017-10-26 |
4 |
AS |
$18.39 |
$144,618 |
D/D |
(7,862) |
24,116 |
|
- |
|
Shohet Stephen B. |
Director |
|
2017-10-26 |
4 |
OE |
$10.77 |
$84,674 |
D/D |
7,862 |
31,978 |
|
- |
|
Gerst Diane G. |
EVP, QA & Regulatory Affairs |
|
2017-10-24 |
4 |
AS |
$18.29 |
$9,568 |
D/D |
(523) |
33,302 |
|
- |
|
Shohet Stephen B. |
Director |
|
2017-10-19 |
4 |
AS |
$18.34 |
$144,195 |
D/D |
(7,862) |
24,116 |
|
- |
|
Shohet Stephen B. |
Director |
|
2017-10-19 |
4 |
OE |
$10.77 |
$84,674 |
D/D |
7,862 |
31,978 |
|
- |
|
Gerst Diane G. |
EVP, QA & Regulatory Affairs |
|
2017-10-17 |
4 |
AS |
$18.48 |
$9,665 |
D/D |
(523) |
33,825 |
|
- |
|
Peters William J |
CFO, SVP & Treasurer |
|
2017-10-13 |
4 |
AS |
$18.56 |
$56,176 |
D/D |
(3,026) |
83,496 |
|
- |
|
Shohet Stephen B. |
Director |
|
2017-10-12 |
4 |
AS |
$18.73 |
$147,219 |
D/D |
(7,862) |
24,116 |
|
- |
|
Shohet Stephen B. |
Director |
|
2017-10-12 |
4 |
OE |
$10.77 |
$84,674 |
D/D |
7,862 |
31,978 |
|
- |
|
Gerst Diane G. |
EVP, QA & Regulatory Affairs |
|
2017-10-05 |
4 |
AS |
$18.87 |
$159,376 |
D/D |
(8,444) |
34,348 |
|
- |
|
956 Records found
|
|
Page 26 of 39 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|